Electrochemical biosensors Market Opportunities and Analysis of Top Key Player Forecasts To 2023
Market Research Future are publish a new
research reports On “Electrochemical biosensors
Market Research Report- Global Forecast Till 2022” in healthcare sector
which is included market strategy, vendors, segmentation etc. The worldwide Electrochemical Biosensors Market is projected to grow at a CAGR of 9.7% and is expected to reach USD 23707.2 million by 2022.
Over the past few years nanotechnology has becoming
increasingly essential in the field of biosensors. The performance and
sensitivity of biosensors is incredibly enhanced with the combination of
nanomaterial’s into their construction. The biosensors works on various
technologies which include electrochemical biosensors, optical biosensors,
thermal biosensors and piezoelectric biosensors. This report by MRFR majorly
focuses on the electrochemical biosensors which holds the largest market share
among all others biosensor technologies. The Electrochemical biosensors plays a
major role in the field of healthcare which include applications such as
diagnosis, patient monitoring and many others. The end user such as point of
care testing, diagnostics centers, research laboratories and various others
influence the growth of the market.
Some Electrochemical
biosensors key players in this market are: F. Hoffmann-La Roche AG, Medtronics,
Bayer AG, Abbott Laboratories, I-SENS, Inc, Siemens Healthcare GmbH and
others.
kThe global market of electrochemical biosensors is
growing rapidly at the CAGR of around 9.7% for the forecasted period. The
growth of the market is likely to driven by increasing diabetic population,
rising prevalence of chronic and lifestyle induced disease, increasing demand
for POCT, increasing application of biosensors in various industries. However,
factors such as strict regulatory requirements, reimbursement policies issues
in healthcare systems is further hampering the market.
Global Electrochemical biosensors market has been
segmented on the basis of applications which comprises of diagnosis, monitoring
and others. Furthermore on the basis of end users the market is segmented into
point of care testing, diagnostics center, research laboratories and others.
North America accounted for the
largest market share with 43.0% of the global electrochemical biosensors market
in the year 2016.
By end users point of care
testing market holds the largest market share.
By application diagnosis
segment accounted for the largest market share and expected to reach 12689.9
million in the year 2022.
Asia-Pacific pacific projected
to be the fastest growing region with a growth rate of 10.0% for the forecasted
period.
North America is the largest market of global
electrochemical biosensors market which is expected to grow at the CAGR of
9.4%. In North America, electrochemical biosensor market is driven due to
increasing health awareness, rising chronic and lifestyle diseases,
technological developments in healthcare applications, and appropriate
insurance coverage.
Usage of biosensor technology in North America is
higher as compared to other regions of the world due to technological
advancements and broader application areas in different industries. Since, the
healthcare expenditure is high in North America, biosensor devices are used
extensively for accurate, reliable and quick results for early detection and
prevention of diseases.
Europe is the second largest market for
electrochemical biosensors which is expected to grow at a CAGR of 9.8%.
Asia Pacific region is expected to be fastest
growing region of this market. The electrochemical biosensors market in
Asia-Pacific region is growing due to increasing awareness of clinical
outcomes, large population base, rise in geriatric population, increase in
diabetic population and technological advancement in medical devices and
equipment. The awareness of various diseases and requirement of high quality
care is increasing day by day. For instance, according to a study conducted by
National Centre for Biotechnology Information (NCBI) in 2012, approximately 60%
of Asian population was suffering from diabetes and the prevalence of diabetes
is increasing. In addition, Asia-Pacific has become one of the attractive
markets for medical device companies due to low regulatory requirements and low
cost manufacturing of devices.
TABLE OF CONTENTS
1 REPORT
PROLOGUE
1.1 Introduction
1.1.1 Global Electrochemical
Biosensors Market, By Application
1.1.2 Global Electrochemical
Biosensors Market, By End User
1.1.3 Global Electrochemical
Biosensors Market, By Region
2
INTRODUCTION
2.1 Definition
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3
RESEARCH METHODOLOGY
4 MARKET
DYNAMICS
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Diabetic Population
4.2.2 Rising Prevalence Of Chronic
And Lifestyle Induced Disease
4.2.3 Increasing Demand For POCT
4.2.4 Increasing Application Of
Biosensors In Various Industries
4.3 Restraints
4.3.1 Strict Regulatory Requirements
4.3.2 Reimbursement Policies Issues
In Healthcare Systems
4.4 Opportunities
4.4.1 Opportunity From Increasing
Demand Of Personalized Medicine
5
MARKET FACTOR ANALYSIS
…Continued
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment